At Lonza, we've spearheaded initiatives that have significantly improved manufacturing processes, integrating quality metrics with risk management strategies to ensure exemplary compliance and product integrity. As a seasoned Quality Site Head with over a decade on the Board of Directors at Dixon Hightower Inc., my strategic insight and governance have been pivotal in steering corporate direction and upholding rigorous quality standards.My tenure at Polpharma Biologics, although brief, was marked by leading quality operations that fortified the company's commitment to excellence. With a robust foundation in FDA regulations, CAPA, and deviation management, our team has consistently delivered on the promise of quality, underpinning the innovation and reliability that drive the biotech industry forward.